What is the treatment for ringworm in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ringworm in children should be treated with oral antifungal medications, with griseofulvin and terbinafine being the most widely used first-line treatments, as they have good evidence of efficacy 1. The choice of systemic therapy should be directed by the causative dermatophyte and/or local epidemiology, with terbinafine being more efficacious against Trichophyton species and griseofulvin more effective against Microsporum species 1. Some key points to consider when treating ringworm in children include:

  • Topical therapy alone is not recommended for the treatment of tinea capitis, and oral therapy is generally indicated to achieve both clinical and mycological cure 1
  • The dose of griseofulvin or terbinafine should be determined based on the child's body weight, with griseofulvin dosed at 15-20 mg/kg/day for 6-8 weeks for children under 50 kg, and terbinafine dosed at 625 mg/day for 2-4 weeks for children under 20 kg 1
  • Treatment failure should be initially considered due to lack of compliance, suboptimal absorption of drug, relative insensitivity of the organism, and reinfection, and second-line therapy with itraconazole may be considered in cases of treatment failure 1
  • Children receiving appropriate therapy should be allowed to attend school or nursery, and index cases due to T. tonsurans warrant screening of all family members and close contacts and treatment for those positive cases 1

From the FDA Drug Label

DOSAGE AND ADMINISTRATION ... Pediatric Use: Approximately 7.3 mg per kg of body weight per day of ultramicrosize griseofulvin is an effective dose for most pediatric patients.

On this basis, the following dosage schedule is suggested: 16 to 27 kg: 125 mg to 187.5 mg daily. Over 27 kg: 187. 5 mg to 375 mg daily Children and infants 2 years of age and younger – dosage has not been established.

The treatment for ringworm in children is griseofulvin. The dosage is based on the child's weight:

  • For children weighing 16 to 27 kg, the suggested dose is 125 mg to 187.5 mg daily.
  • For children weighing over 27 kg, the suggested dose is 187.5 mg to 375 mg daily. However, the dosage for children 2 years of age and younger has not been established 2.

From the Research

Treatment Options for Ringworm in Children

The treatment for ringworm in children typically involves the use of systemic anti-fungal medications. Some of the commonly used medications include:

  • Griseofulvin (Grifulvin) 3
  • Terbinafine (Lamisil Granules) 3, 4, 5, 6
  • Itraconazole 4, 5, 6, 7
  • Fluconazole 4, 5, 6, 7

Duration of Treatment

The duration of treatment for ringworm in children can vary depending on the medication used. For example:

  • Griseofulvin is usually taken for 6 to 8 weeks 3
  • Terbinafine is usually taken for 6 weeks 3 or 2-3 weeks 4
  • Itraconazole is usually taken for 2-3 weeks 4 or 6 weeks 6
  • Fluconazole is usually taken for 2-3 weeks 4 or 6 weeks 6

Efficacy of Treatment

Studies have shown that these medications are effective in treating ringworm in children. For example:

  • Terbinafine and griseofulvin have similar efficacy in treating Trichophyton species infections 4, 6
  • Itraconazole and griseofulvin have similar efficacy in treating Trichophyton species infections 4, 6
  • Fluconazole and griseofulvin have similar efficacy in treating Trichophyton species infections 4, 6

Safety and Side Effects

The safety and side effects of these medications have also been studied. For example:

  • Griseofulvin has been associated with gastrointestinal side effects 4
  • Terbinafine, itraconazole, and fluconazole have been shown to have a favorable adverse-effects profile 4, 5, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.